友芝友生物-B(02496)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02496 友芝友生物-B

已收盘 09-30 13:39:03

3.190

-0.010

-0.31%

最高3.190	最低3.190	成交量0.00
今开3.190	昨收3.200	日振幅0.00%
总市值6.19亿	流通市值5.73亿	总股本1.94亿
成交额0.00	换手率0.00%	流通股本1.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"友芝友生物-B","latestPrice":3.19,"timestamp":1790746743450,"preClose":3.2,"halted":0,"volume":0,"delay":0,"changeRate":-0.003125000000000072,"floatShares":179479113,"shares":194000000,"eps":-0.5113590328591716,"marketStatus":"已收盘","change":-0.01,"latestTime":"09-30 13:39:03","open":3.19,"high":3.19,"low":3.19,"amount":0,"amplitude":0,"askPrice":3.19,"askSize":600,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.1940741030811358,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":5,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":3.2,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02496","defaultTab":"news","newsList":[{"id":"1176439709","title":"友芝友生物-B（02496）调整公司秘书及法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=1176439709","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176439709?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:37","pubTimestamp":1790757420,"startTime":"0","endTime":"0","summary":"2026年9月30日，武汉友芝友生物制药股份有限公司公告称，自2026年9月30日起，公司管理层将进行以下调整：。根据香港联合交易所有限公司于2026年9月18日的确认，现任联席公司秘书郑建华已符合《上市规则》第3.28条及第8.17条的规定，可在豁免期于2026年9月24日届满后继续担任公司秘书。届时，郑建华将出任公司的唯一公司秘书。麦善琪获委任为新的法律程序文件代理人，任职自2026年9月30日起生效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274126","title":"友芝友生物-B(02496)：麦善琪获委任为法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671274126?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:36","pubTimestamp":1790757376,"startTime":"0","endTime":"0","summary":"于赖女士辞任后，郑先生将继续担任本公司的唯一公司秘书。赖女士已辞任本公司根据上市规则第19A.13条及香港法例第622章公司条例第16部规定，代表本公司于香港接收法律程序文件及通知书的授权代表，自2026年9月30日起生效;及麦善琪女士已获委任为法律程序文件代理人，自2026年9月30日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103869070","title":"友芝友生物-B2026年上半年营收3,314.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103869070","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103869070?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:36","pubTimestamp":1789565797,"startTime":"0","endTime":"0","summary":"本期信息显示，友芝友生物-B在2026年上半年实现营收3,314.3万元，同比下降10.88%。从收入构成来看，许可费收入为2,422.7万元，较上年同期的471.7万元大幅增长，但同期研发服务收入891.6万元，相比上年同期的3,247.0万元大幅回落，导致总营收出现下滑。公司经营现金流净额为-2,663.4万元，上年同期为1,220.3万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"友芝友生物-B2026年上半年营收3,314.3万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566385","title":"友芝友生物-B(02496)9月10日上午起复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666566385?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:42","pubTimestamp":1789000941,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，武汉友芝友生物制药股份有限公司的H股份(证券代号：02496)将于今天(2026年9月10日)上午九时正起恢复买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136791960","title":"友芝友生物-B（02496）拟发行3,559.24万股境内股 募资约8,648.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136791960","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136791960?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:42","pubTimestamp":1788961372,"startTime":"0","endTime":"0","summary":"2026年9月9日，友芝友生物-B公告称，公司已于2026年8月30日与袁谦博士、周宏峰博士及Zhou Pengfei博士签订股份认购协议，拟以每股人民币2.43元的价格，向三名认购方发行合计35,592,400股新境内股份，认购总价约人民币8,648.95万元；扣除相关成本、开支及费用后，预计所得款项净额约人民币8,300万元。\\n\\n应公司要求，友芝友生物-B H股自2026年8月31日9:00起停牌，公司已申请自2026年9月10日9:00起恢复买卖。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666366585","title":"友芝友生物-B(02496.HK)拟折让约14.86%发行合共3559.24万股境内股份 9月10日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666366585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666366585?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:41","pubTimestamp":1788961283,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163321977","title":"友芝友生物-B更新8月股份变动月报，股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1163321977","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163321977?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:39","pubTimestamp":1788424788,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年9月3日发布截至2026年8月31日的证券变动月报表。报告显示，公司本月末法定/注册股本总额为人民币193,849,200元，相比上月底无变化。其中，H股股本为179,479,113股，内资股股本为14,370,087股，两类股份数量均保持不变。在已发行股份及库存股份变动方面，H股和内资股在月内均未发生新增发行或回购注销，已发行股份总数继续维持在H股179,479,113股、内资股14,370,087股的水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663234790","title":"友芝友生物-B于8月31日起短暂停牌 待刊发内幕消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2663234790","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663234790?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:05","pubTimestamp":1788138300,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端友芝友生物-B（02496）发布公告，公司股份已自2026年8月31日上午九时正起暂停于香港联合交易所有限公司买卖，以待根据公司收购、合并及股份回购守则刊发载有公司内幕消息的公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-08-31/doc-iniqehxc9216031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663236270","title":"友芝友生物-B(02496.HK)8月31日起短暂停牌 待刊发内幕消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2663236270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663236270?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:56","pubTimestamp":1788137784,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142371189","title":"友芝友生物-B（02496）8月31日起停牌 待发布涉及公司收购合并及股份回购守则的内幕消息","url":"https://stock-news.laohu8.com/highlight/detail?id=1142371189","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142371189?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:56","pubTimestamp":1788137770,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司8月31日在港交所发布公告称，应公司要求，其股份自2026年8月31日上午九时正起暂停买卖。停牌原因系公司将根据《公司收购、合并及股份回购守则》刊发载有内幕消息的公告。公司提醒投资者，港交所及香港结算所有限公司对本公告内容的准确性或完整性不承担任何责任，并明确表示概不因本公告全部或任何部分内容而承担任何损失责任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663023622","title":"友芝友生物-B(02496.HK)8月31日起短暂停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2663023622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663023622?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:55","pubTimestamp":1788137734,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662806315","title":"友芝友生物-B(02496)发布中期业绩 净亏损626万元 同比收窄89.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662806315","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662806315?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:15","pubTimestamp":1787908537,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布截至2026年6月30日止6个月中期业绩，集团收入人民币3314.3万元，同比减少10.87%;净亏损626万元，同比收窄89.36%;研发开支1758.1万元，同比减少70.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131513878","title":"友芝友生物-B2026年中期财报：营收3,314.30万元，净亏损626.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1131513878","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131513878?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:54","pubTimestamp":1787907298,"startTime":"0","endTime":"0","summary":"2026年上半年，公司营收3,314.30万元，同比下降10.88%。同期净亏损626.00万元，上年同期亏损5,883.40万元，亏损同比收窄约89.36%。本期毛利2,525.60万元，毛利率达76.2%，而上年同期毛利率约为20.62%。经营活动现金流量由上年同期净流入1,220.00万元转为本期净流出2,660.00万元。从成本结构看，报告期内公司研发开支1,758.10万元，占总营收约53%。报告期内主要收入来源包括许可费收入和研发服务收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"友芝友生物-B2026年中期财报：营收3,314.30万元，净亏损626.00万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127507772","title":"友芝友生物-B将于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1127507772","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127507772?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:46","pubTimestamp":1787042809,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司（股票代码：02496，股票简称：友芝友生物-B）公告称，董事会已排定于2026年8月28日（星期五）召开会议。董事会将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩报告，并讨论相关发布事宜及其他事项。董事会由董事长、执行董事兼首席执行官Zhou Pengfei博士召集。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658226229","title":"友芝友生物-B创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2658226229","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658226229?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:31","pubTimestamp":1786519862,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186473636","title":"友芝友生物-B7月股份变动月报，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1186473636","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186473636?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:44","pubTimestamp":1785919496,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年8月5日发布2026年7月股份变动月报。报告期覆盖2026年7月，公告显示公司股本结构及发行股份数量在本月内均无显著变动。其中，H股股本维持在179,479,113股，内资股股本维持在14,370,087股，月度内均未发生增减变化。公司表示期内未进行任何股份增发或回购注销事宜，H股和内资股股本数量保持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125309281","title":"友芝友生物-B6月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125309281","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125309281?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:52","pubTimestamp":1783327960,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年7月6日发布2026年6月股份变动月报表。报告期内，公司注册股本总额保持在人民币193,849,200元，其中H股179,479,113股与内资股14,370,087股维持不变，合计已发行股份数量无新增或回购注销情况。公司确认其公众持股量符合香港联交所相关上市规定。公司强调，其持续严格遵守香港联交所《上市规则》及相关法律法规各项规定。本次公告由联席公司秘书郑建华签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163663396","title":"友芝友生物-B 2026年5月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163663396","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163663396?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:36","pubTimestamp":1780475794,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年6月3日披露2026年5月股份变动月报，报告期为截至2026年5月31日。根据公告披露数据，截至当月末，公司股本基本维持稳定，未发生新增发行、回购或注销股份的情况。报告显示，截至2026年5月31日，公司的法定/注册股本总额为193,849,200元人民币，其中H股179,479,113股，面值每股1元，内资股14,370,087股，面值每股1元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311357","title":"友芝友生物-B(02496)：M701“CD3/EpCAM双特异性抗体”两项临床研究数据将于2026ASCO年会进行展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637311357?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:05","pubTimestamp":1779451520,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，公司核心国家1类创新药M701“CD3/EpCAM双特异性抗体”的两项临床研究结果将于2026年美国临床肿瘤学会(ASCO)年会上进行展示：针对恶性腹水(MA)的III期注册临床研究、针对非小细胞肺癌(NSCLC)相关恶性胸水(MPE)的II期临床研究。M701的上市申请已于2026年5月获中国国家药品监督管理局药品审评中心(CDE) 受理，有望成为中国首个恶性胸腹水标准治疗方案。相比欧盟获批的卡妥索单抗，M701展现出更优的安全性与切实的临床可及性;相比穿刺引流或局部化疗，M701则体现出更高的有效率和更持久的积液控制能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635704166","title":"友芝友生物-B(02496)：方丽娟获选举为第二届监事会职工代表监事","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635704166?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:35","pubTimestamp":1778834112,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，石剑博士(石博士)因个人职业发展原因而辞去本公司职工代表监事职务，自2026年5月15日起生效。本公司抗体平台部副总监方丽娟女士(方女士)于2026年5月15日获职工代表大会民主选举为第二届监事会职工代表监事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.yzybio.com","stockEarnings":[{"period":"1week","weight":-0.0303},{"period":"1month","weight":-0.0303},{"period":"3month","weight":-0.1579},{"period":"6month","weight":-0.2252},{"period":"1year","weight":-0.5294},{"period":"ytd","weight":-0.601}],"compareEarnings":[{"period":"1week","weight":-0.0225},{"period":"1month","weight":-0.0415},{"period":"3month","weight":0.0718},{"period":"6month","weight":-0.0236},{"period":"1year","weight":-0.0789},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"武汉友芝友生物制药股份有限公司是一家主要从事发现、开发及商业化抗肿瘤双特异性抗体方面的新型创新药物的中国公司。该公司致力于开发用于治疗癌症相关并发症、癌症及老年性眼科疾病的基于双特异性抗体（BsAb）疗法，以解决肿瘤学及老年眼科病领域的医疗需求。该公司的核心产品M701是一种靶向人癌细胞表面抗原EpCAM和人T细胞表面抗原CD3的重组BsAb。该公司的产品管线还包括Y101D、Y332、Y225等。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.063412},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.118093},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.131504},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.057977},{"month":5,"riseRate":0,"avgChangeRate":-0.055072},{"month":6,"riseRate":0.666667,"avgChangeRate":0.03104},{"month":7,"riseRate":0.333333,"avgChangeRate":0.022644},{"month":8,"riseRate":0,"avgChangeRate":-0.093838},{"month":9,"riseRate":0.666667,"avgChangeRate":0.102603},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.141485},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.141267},{"month":12,"riseRate":1,"avgChangeRate":0.323325}],"exchange":"SEHK","name":"友芝友生物-B","nameEN":"YZYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"友芝友生物-B(02496)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供友芝友生物-B(02496)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"友芝友生物-B,02496,友芝友生物-B股票,友芝友生物-B股票老虎,友芝友生物-B股票老虎国际,友芝友生物-B行情,友芝友生物-B股票行情,友芝友生物-B股价,友芝友生物-B股市,友芝友生物-B股票价格,友芝友生物-B股票交易,友芝友生物-B股票购买,友芝友生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"友芝友生物-B(02496)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供友芝友生物-B(02496)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}